Sv. Mclennan et al., HIGH GLUCOSE-CONCENTRATION CAUSES A DECREASE IN MESANGIUM DEGRADATION- A FACTOR IN THE PATHOGENESIS OF DIABETIC NEPHROPATHY, Diabetes, 43(8), 1994, pp. 1041-1045
Citations number
25
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Mesangium enlargement is a constant feature of diabetic nephropathy an
d is likely to be important in the pathogenesis of this diabetic compl
ication. Whether decreased degradation of mesangium plays any role in
causing the enlargement is uncertain. We developed a system of prepari
ng radioactively labeled mesangium matrix from mesangial cell cultures
to be used as substrates for studies of mesangium degradation. Degrad
ation is commenced by growing mesangial cells on the labeled matrix an
d monitored by the release of radioactivity into the culture medium. H
igh glucose concentration (30 mM), whether present 1) when the matrix
is being made or 2) when the degradation is taking place, reduces the
rate of mesangium degradation. The second but not the first of these t
wo phenomena was abolished by aminoguanidine. Phorbol 12-myristate 13-
acetate, added in a manner to antagonize the action of protein kinase
C, inhibited mesangium degradation and was not able to nullify the eff
ect of high glucose, Thus it appears unlikely that a high glucose conc
entration inhibits mesangium degradation by increasing mesangial cell
protein kinase C activity. We conclude that decreased degradation of m
esangium as a result of hyperglycemia may play a role in causing the m
esangium enlargment that occurs in diabetic nephropathy.